| dc.contributor.author | Kankanamge, A. | |
| dc.contributor.author | Liyanage, T.G. | |
| dc.contributor.author | Mudduwa, L.K.B. | |
| dc.date.accessioned | 2024-09-02T05:22:06Z | |
| dc.date.available | 2024-09-02T05:22:06Z | |
| dc.date.issued | 2021-08-14 | |
| dc.identifier.citation | Kankanamge, A., Liyanage, T.G. and Mudduwa, L.K.B. (2021) ‘Identifying thyroid follicular proliferations that need lobectomy; value of the Bethesda category 4’, <i>Galle Medical Journal</i>, 26(2), p. 68-73. Available at: https://doi.org/10.4038/gmj.v26i2.8088. | en_US |
| dc.identifier.uri | http://ir.lib.ruh.ac.lk/handle/iruor/17335 | |
| dc.description.abstract | Introduction: Thyroid follicular proliferations (TFPs) identified on fine needle aspiration cytology can be either follicular lesions of undetermined significance; Bethesda category 3 or follicular neoplasms and lesions suspicious for a follicular neoplasm; Bethesda category 4. The purpose of categorizing to Bethesda category 4 is to identify a thyroid nodule that might be a follicular carcinoma and triage it for thyroid lobectomy. This study was designed to determine the predictive value of categorizing TFPs to Bethesda category 4 in deciding on lobectomy for cytologically identified TFPs. Methods: This retrospective study included all patients with TFPs identified on cytology, and had a subsequent histological diagnosis, at our unit, over a period of two years. TFPs were categorized into either Bethesda category 3 or 4 on cytology, according to the Bethesda system. Sensitivity, specificity and positive (PPV) and negative predictive values (NPV) for Bethesda category 4 in identifying neoplastic TFPs and implied risk of malignancy for Bethesda category 3 and 4 were calculated taking histopathology as the gold standard. A total of 52 TFPs (Bethesda category 3; n = 39, Bethesda category 4; n = 13) were included. Subsequent histology has confirmed 18 neoplastic and 34 non-neoplastic TFPs. Sensitivity and specificity of Bethesda category 4 in identifying neoplastic TFPs were 66.66% and 97.05% respectively. PPV and NPV of Bethesda category 4 were 92.3% and 84.6% respectively. Implied risk of malignancy for Bethesda category 3 and 4 were 5.12% and 15.38% respectively. Conclusions: Bethesda category 4 predicts the TFPs that need thyroid lobectomy to triage for follicular carcinoma. The Bethesda category 3 and 4 carry an implied risk of malignancy comparable to the expected values given in Bethesda system. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Galle Medical Association | en_US |
| dc.subject | Bethesda system | en_US |
| dc.subject | cytology | en_US |
| dc.subject | follicular proliferations | en_US |
| dc.subject | neoplastic and non-neoplastic lesions | en_US |
| dc.subject | thyroid | en_US |
| dc.title | Identifying Thyroid Follicular Proliferations that Need Lobectomy; value of the Bethesda Category 4 | en_US |
| dc.type | Article | en_US |